Remove contact
article thumbnail

HHS Proposes Significant Amendments to Part 2 Regulations Governing the Confidentiality of Substance Use Disorder Records

C&M Health Law

Earlier this week, the United States Department of Health and Human Services (“HHS”) released a Notice of Proposed Rulemaking (“NPRM”) that proposes to make sweeping changes to regulations at 42 C.F.R. part 2 (“Part 2”) governing the confidentiality of substance use disorder (“SUD”) records.

article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

As a result, if a patient and a practitioner have appropriately established a telemedicine relationship on or before November 11, 2023, the same telemedicine flexibilities that have governed the relationship to that point will continue to be permitted until November 11, 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Senate Committee’s PREVENT Pandemics Act Draft Released: What to Know

Healthcare Law Today

Stakeholders interested in submitting comments to the HELP Committee, or seeking additional information on the PREVENT Pandemics Act or related measures, should contact Jennifer Walsh, Director of Public Affairs with Foley & Lardner at jwalsh@foley.com or (202) 295-4762. Sources: Senate Press Release and PDF

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

With support from the Foundation for Opioid Response Efforts (FORE), public health law experts from Indiana University McKinney School of Law and the Temple University Center for Public Health Law Research at the Beasley School of Law recently embarked on a systematic review of U.S.

article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

In the proposed rules regarding buprenorphine DEA says that a practitioner must be registered in the state where he/she is located, however, DEA does not address this issue in its proposed rules governing the special registration requirements generally. 21 U.S.C. § 802(17).

article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. million Centers for Medicare & Medicaid Services (CMS) $4.1

Medicaid 104